Indrayani Biotech Ltd

NSE: INDRANIB · BSE: 526445 · Food, Beverages & Tobacco · 22 announcements

Share price: ₹10.08
Market cap: ₹54.10 Cr
Revenue (annual): ₹137.8 Cr
Net profit (annual): ₹2.16 Cr
P/E (TTM): 31.6×Sector 28.6×
Promoter holding: 32.92%-0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Fund Raise 6 Other Announcement 4 Management Change 2 Legal & Regulatory 2 Financial Results 2 Capital Structure Change 2 Board Meeting Outcome 2 Price Movement Clarification 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

9 Apr 2026 18:06 IST BSE

Board Meeting Outcome

Indrayani Biotech Board Meeting Outcome

Indrayani Biotech's board approved exploring the demerger of its food division into a separate company and constituted a 'Restructuring Committee' for evaluation. Additionally, M/S Vaithianathan & Associates was appointed as Internal Auditor for FY 2025-26 and 2026-27.

Read the filing ↗

6 Apr 2026 17:33 IST BSE

Board Meeting Outcome

Indrayani Biotech Board Meeting Outcome

Indrayani Biotech Ltd has scheduled a Board Meeting on April 9, 2026, to evaluate a proposal for the demerger of one of its units into a separate entity. The move is aimed at unlocking shareholder value. The company's trading window remains closed until 48 hours after the declaration of financial results.

Read the filing ↗